Efficacy and safety of agomelatine (25-50 Mg/Day) versus escitalopram (10-20 Mg/Day) in severe generalized anxiety disorder

Authors
Category Primary study
ConferenceAustralian and New Zealand Journal of Psychiatry
Year 2018
This article has no abstract
Epistemonikos ID: bc4b8d73e3c38de298ac272dc4d6435d050ca6c0
First added on: Apr 29, 2026